Who gets Prostate cancer?

['Mamela leqephe lena']

Ke bo-mang ba tšoaroang ke kankere ea tšoelesa ea senya?

Kankere ea tšoelesa ea senya ke lefu le tšoaetsang banna haholo,'me kotsi ea ho tšoaroa ke lona e eketseha ha motho a ntse a tsofala.

Hangata e fumanoa ho banna ba lilemo tse fetang 65.

Lintho tse ling tse ka eketsang kotsi ea ho tšoaroa ke kankere ea tšoelesa ea senya li akarelletsa:

1. Lilemo: Kotsi ea ho tšoaroa ke kankere ea tšoelesa ea senya e eketseha ha motho a ntse a hōla,'me boholo ba banna ba tšoaroang ke kankere ena ba lilemo tse ka holimo ho 65.

2. Histori ea lelapa: Banna ba nang le histori ea lelapa ea kankere ea tšoelesa ea senya, haholo-holo ntate kapa mor'abo motho ea nang le lefu lena, ba kotsing e khōlō ea ho tšoaroa ke kankere ea tšoelesa ea senya.

3. Morabe: Banna ba Maafrika le Maamerika ba kotsing e khōlō ea ho tšoaroa ke kankere ea tšoelesa ea senya'me ba ka 'na ba fumanoa ba le banyenyane haholo ba bile ba tšoeroe ke mofuta o matla oa lefu lena.

4. Liphatsa tsa lefutso: Liphetoho tse itseng tsa liphatsa tsa lefutso tse futsitsoeng, tse kang liphatsa tsa lefutso tsa BRCA1 le BRCA2, li ka eketsa kotsi ea ho tšoaroa ke kankere ea tšoelesa ea senya.

5. Lijo: Lijo tse nang le nama e khubelu le lihlahisoa tsa lebese tse nang le mafura a mangata li ka eketsa kotsi ea ho tšoaroa ke kankere ea tšoelesa ea senya, athe lijo tse nang le litholoana le meroho e mengata li ka fokotsa kotsi eo.

6. Botenya: Ho nona haholo kapa ho nona ho ka eketsa kotsi ea ho tšoaroa ke kankere ea tšoelesa ea senya, hammoho le monyetla oa hore kankere e be matla haholoanyane.

7. Mekhoa ea bophelo: Mekhoa e meng ea bophelo, e kang ho tsuba le ho se ikoetlise, e ka eketsa kotsi ea ho tšoaroa ke kankere ea tšoelesa ea senya.

Ke habohlokoa ho hlokomela hore le hoja lintho tsena li ka eketsa kotsi ea ho tšoaroa ke kankere ea tšoelesa ea senya, hase banna bohle ba nang le lintho tsena tse ka bakang kotsi ba tla tšoaroa ke lefu lena,'me banna ba bang ba se nang lintho tse ka bakang kotsi ba ntse ba ka fumanoa ba tšoeroe ke kankere ea tšoelesa ea senya.

Ho hlahlojoa khafetsa le ho buisana le ngaka ka lintho tse u tšoenyang ho ka u thusa hore u fumane kankere ea tšoelesa ea senya kapele, ha e sa ntse e ka phekoleha.

['Litšupiso']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Shimodaira K, Nakashima J, Nakagami Y, Hirasawa Y, Hashimoto T, Satake N, Gondo T, Namiki K, Ohori M, Ohno Y: Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy. Urol J. 2020, 17 (1): 42-49.

Advanced prostate cancer gets a new foe. Johns Hopkins Med Lett Health After 50. 2013, 25 (7): 8.

Vera Badillo FE: Metastatic prostate cancer gets into the biomarker era. Can Urol Assoc J. 2022, 16 (10): 333.

Gerard MJ, Frank-Stromborg M: Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications. Oncol Nurs Forum. 1998, 25 (9): 1561-9.

McDowell ME, Occhipinti S, Chambers SK: The influence of family history on cognitive heuristics, risk perceptions, and prostate cancer screening behavior. Health Psychol. 2013, 32 (11): 1158-69.

Razzaghi MR, Mazloomfard MM, Malekian S, Razzaghi Z: Association of macrophage inhibitory factor -173 gene polymorphism with biological behavior of prostate cancer. Urol J. 2019, 16 (1): 32-36.

['Tlhokomeliso: tsa bongaka']

["Websaete ena e etselitsoe ho ruta le ho fana ka boitsebiso feela'me ha e fane ka keletso ea bongaka kapa litšebeletso tsa litsebi."]

["Boitsebiso bo fanoeng ha boa lokela ho sebelisoa ho hlahloba kapa ho phekola bothata ba bophelo bo botle kapa lefu,'me ba batlang keletso ea bongaka ba lokela ho buisana le ngaka e nang le lengolo la tumello."]

['Ka kōpo hlokomela hore neural net e hlahisang likarabo lipotsong, ha e nepahale haholo-holo ha ho tluoa linomorong.']

["Kamehla batla keletso ea ngaka ea hao kapa mofani e mong ea tšoanelehang oa tlhokomelo ea bophelo mabapi le boemo ba bongaka. Le ka mohla u se ke ua hlokomoloha keletso ea setsebi sa bongaka kapa ua lieha ho e batla ka lebaka la ntho eo u e balileng websaeteng ena. Haeba u nahana hore u ka 'na ua ba le boemo ba tšohanyetso ba bongaka, letsetsa 911 kapa u ee kamoreng ea tšohanyetso e haufi hang-hang. Ha ho kamano ea ngaka le mokuli e bōptjoang ke websaeteng ena kapa tšebeliso ea eona. BioMedLib kapa basebetsi ba eona, kapa motho leha e le ofe ea tlatsetsang ho websaeteng ena, ha a etse litemoso, tse hlakileng kapa tse sa hlakang, mabapi le boitsebiso bo fanoeng mona kapa tšebeliso ea eona."]

['Tlhokomeliso: litokelo tsa bangoli']

['Molao oa Digital Millennium Copyright Act oa 1998, 17 U.S.C. § 512 (DMCA) o fana ka litokelo tsa beng ba litokelo tsa bangoli ba lumelang hore thepa e hlahang Inthaneteng e hatakela litokelo tsa bona tlasa molao oa litokelo tsa bangoli ba U.S. ']

['Haeba u lumela ka tumelo e ntle hore litaba leha e le life kapa thepa e fumanehang mabapi le websaeteng kapa litšebeletso tsa rona e tlōla litokelo tsa hau tsa molao, uena (kapa moemeli oa hau) a ka re romella tsebiso e kōpang hore litaba kapa thepa e tlosoe, kapa ho fihlella ho eona ho thibeloe. ']

['Ditsebiso di tlameha ho romelwa ka lengolo ka imeile (bona karolo ya "Ho iteanya" bakeng sa aterese ya imeile). ']

["DMCA e hloka hore tsebiso ea hao ea ho tlōla ha molao ho boleloang hore e na le boitsebiso bo latelang: (1) tlhaloso ea mosebetsi o sirelelitsoeng ka molao o boleloang hore o tlōloa; (2) tlhaloso ea litaba tse boleloang hore li tlōla molao le boitsebiso bo lekaneng ho re lumella ho fumana litaba; (3) boitsebiso ba ho ikopanya le uena, ho akarelletsa aterese ea hau, nomoro ea fono le aterese ea imeile; (4) polelo ea hau ea hore u na le tumelo e ntle ea hore litaba ka tsela e belaelloang ha e lumelloe ke mong'a litokelo tsa molao, kapa moemeli oa eona, kapa ka ts'ebetso ea molao leha e le ofe; "]

['(5) polelo e saennweng ke wena, tlasa kotlo ya ho hlapanya leshano, ya hore tlhahisoleseding e tsebisong e nepahetse le hore o na le matla a ho tiisa ditokelo tsa mongodi tseo ho thweng di a tlolwa; ']

["le (6) ho saena ka letsoho kapa ka elektronike ha mong'a litokelo tsa bangoli kapa motho ea lumeletsoeng ho nka khato lebitsong la mong'a litokelo tsa bangoli. "]

['Ho hloleha ho kenyelletsa tlhahisoleseding yohle e ka hodimo ho ka baka ho dieha ha ho sebetswa tletlebo ya hao.']

['Ho Iteanya']

['Ka kōpo re romelle imeile ka potso / tlhahiso leha e le efe.']

Who gets prostate cancer?

Prostate cancer is a disease that primarily affects men, with the risk increasing with age.

It is most commonly diagnosed in men over the age of 65.

Some factors that may increase the risk of developing prostate cancer include:

1. Age: The risk of prostate cancer increases with age, with most cases occurring in men over the age of 65.

2. Family history: Men with a family history of prostate cancer, particularly a father or brother with the disease, have a higher risk of developing prostate cancer themselves.

3. Race: African American men have a higher risk of developing prostate cancer and are more likely to be diagnosed at a younger age and with more aggressive forms of the disease.

4. Genetics: Certain inherited genetic mutations, such as those in the BRCA1 and BRCA2 genes, may increase the risk of developing prostate cancer.

5. Diet: A diet high in red meat and high-fat dairy products may increase the risk of prostate cancer, while a diet rich in fruits and vegetables may decrease the risk.

6. Obesity: Being overweight or obese may increase the risk of developing prostate cancer, as well as the likelihood of the cancer being more aggressive.

7. Lifestyle factors: Certain lifestyle factors, such as smoking and lack of physical activity, may increase the risk of developing prostate cancer.

It is important to note that while these factors may increase the risk of developing prostate cancer, not all men with these risk factors will develop the disease, and some men without any known risk factors may still be diagnosed with prostate cancer.

Regular screening and discussing any concerns with a healthcare provider can help to detect prostate cancer early, when it is most treatable.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.